icon-folder.gif   Conference Reports for NATAP  
 
  International Workshop on HIV & Hepatitis Virus Drug Resistance
5-9 June 2012, Sitges, Spain
Back grey_arrow_rt.gif
 
 
 
Deep sequencing analysis of rilpivirine virologic failures in the Phase III studies ECHO and THRIVE shows no association with the presence of minority resistance-associated variants at baseline
 
 
  Reported by Jules Levin
International Workshop on HIV & Hepatitis Virus
Drug Resistance and Curative Strategies,
Melia Sitges, Spain, 5-9 June 2012
 
Veerle Van Eygen,1 Kim Thys,1 Johan Vingerhoets,1 Carl Van Hove,2 Laurence T Rimsky,1 Jeroen Aerssens,1 Gaston R Picchio3 1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Janssen Pharmaceutica, Beerse, Belgium; 3Janssen Research & Development LLC, Titusville, NJ, USA

resistance1.gif

resistance2.gif

resistance3.gif

resistance4.gif

resistance5.gif

resistance6.gif